A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)

Start Over

Sorry. There are no research sites conducting this study in the radius provided. ( View all Sites )

If you would like to be informed of other studies that may be of interest to you, you may sign up for CenterWatch.com's Patient Notification Service.

Recruitment Status: Open

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.

Powered by